Global And China Pneumococcal Vaccine Market Insights, Forecast To 2027

1 Study Coverage
1.1 Pneumococcal Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pneumococcal Vaccine Market Size Growth Rate by Type
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Market by End User
1.3.1 Global Pneumococcal Vaccine Market Size Growth Rate by End User
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Pneumococcal Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Pneumococcal Vaccine Revenue 2016-2027
2.1.2 Global Pneumococcal Vaccine Sales 2016-2027
2.2 Global Pneumococcal Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Pneumococcal Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Pneumococcal Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Pneumococcal Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Pneumococcal Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Pneumococcal Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Pneumococcal Vaccine Revenue Forecast by Region (2022-2027)

3 Global Pneumococcal Vaccine Competitor Landscape by Players
3.1 Global Top Pneumococcal Vaccine Manufacturers by Sales
3.1.1 Global Pneumococcal Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Pneumococcal Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Pneumococcal Vaccine Manufacturers by Revenue
3.2.1 Key Pneumococcal Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Pneumococcal Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Pneumococcal Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pneumococcal Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Pneumococcal Vaccine Revenue in 2020
3.2.6 Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pneumococcal Vaccine Price by Manufacturers
3.4 Global Pneumococcal Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pneumococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumococcal Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Pneumococcal Vaccine Market Size by Type (2016-2021)
4.1.1 Global Pneumococcal Vaccine Sales by Type (2016-2021)
4.1.2 Global Pneumococcal Vaccine Revenue by Type (2016-2021)
4.1.3 Pneumococcal Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Pneumococcal Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Pneumococcal Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Pneumococcal Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Pneumococcal Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by End User (2016-2027)
5.1 Global Pneumococcal Vaccine Market Size by End User (2016-2021)
5.1.1 Global Pneumococcal Vaccine Sales by End User (2016-2021)
5.1.2 Global Pneumococcal Vaccine Revenue by End User (2016-2021)
5.1.3 Pneumococcal Vaccine Price by End User (2016-2021)
5.2 Pneumococcal Vaccine Market Size Forecast by End User (2022-2027)
5.2.1 Global Pneumococcal Vaccine Sales Forecast by End User (2022-2027)
5.2.2 Global Pneumococcal Vaccine Revenue Forecast by End User (2022-2027)
5.2.3 Global Pneumococcal Vaccine Price Forecast by End User (2022-2027)

6 China by Players, Type and End User
6.1 China Pneumococcal Vaccine Market Size YoY Growth 2016-2027
6.1.1 China Pneumococcal Vaccine Sales YoY Growth 2016-2027
6.1.2 China Pneumococcal Vaccine Revenue YoY Growth 2016-2027
6.1.3 China Pneumococcal Vaccine Market Share in Global Market 2016-2027
6.2 China Pneumococcal Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Pneumococcal Vaccine Players by Sales (2016-2021)
6.2.2 China Top Pneumococcal Vaccine Players by Revenue (2016-2021)
6.3 China Pneumococcal Vaccine Historic Market Review by Type (2016-2021)
6.3.1 China Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
6.3.2 China Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 China Pneumococcal Vaccine Price by Type (2016-2021)
6.4 China Pneumococcal Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Pneumococcal Vaccine Sales Forecast by Type (2022-2027)
6.4.2 China Pneumococcal Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 China Pneumococcal Vaccine Price Forecast by Type (2022-2027)
6.5 China Pneumococcal Vaccine Historic Market Review by End User (2016-2021)
6.5.1 China Pneumococcal Vaccine Sales Market Share by End User (2016-2021)
6.5.2 China Pneumococcal Vaccine Revenue Market Share by End User (2016-2021)
6.5.3 China Pneumococcal Vaccine Price by End User (2016-2021)
6.6 China Pneumococcal Vaccine Market Estimates and Forecasts by End User (2022-2027)
6.6.1 China Pneumococcal Vaccine Sales Forecast by End User (2022-2027)
6.6.2 China Pneumococcal Vaccine Revenue Forecast by End User (2022-2027)
6.6.3 China Pneumococcal Vaccine Price Forecast by End User (2022-2027)

7 North America
7.1 North America Pneumococcal Vaccine Market Size YoY Growth 2016-2027
7.2 North America Pneumococcal Vaccine Market Facts & Figures by Country
7.2.1 North America Pneumococcal Vaccine Sales by Country (2016-2021)
7.2.2 North America Pneumococcal Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Pneumococcal Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Pneumococcal Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Pneumococcal Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Pneumococcal Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Pneumococcal Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Pneumococcal Vaccine Market Facts & Figures by Country
9.2.1 Europe Pneumococcal Vaccine Sales by Country (2016-2021)
9.2.2 Europe Pneumococcal Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Pneumococcal Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Pneumococcal Vaccine Market Facts & Figures by Country
10.2.1 Latin America Pneumococcal Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Pneumococcal Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Pneumococcal Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Pneumococcal Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Pneumococcal Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Pneumococcal Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Pneumococcal Vaccine Products Offered
12.1.5 Pfizer Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Description and Business Overview
12.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Pneumococcal Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 MSD
12.3.1 MSD Corporation Information
12.3.2 MSD Description and Business Overview
12.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 MSD Pneumococcal Vaccine Products Offered
12.3.5 MSD Recent Development
12.4 Sanofipasteur
12.4.1 Sanofipasteur Corporation Information
12.4.2 Sanofipasteur Description and Business Overview
12.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofipasteur Pneumococcal Vaccine Products Offered
12.4.5 Sanofipasteur Recent Development
12.5 CDIBP
12.5.1 CDIBP Corporation Information
12.5.2 CDIBP Description and Business Overview
12.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CDIBP Pneumococcal Vaccine Products Offered
12.5.5 CDIBP Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Pneumococcal Vaccine Products Offered
12.11.5 Pfizer Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Pneumococcal Vaccine Industry Trends
13.2 Pneumococcal Vaccine Market Drivers
13.3 Pneumococcal Vaccine Market Challenges
13.4 Pneumococcal Vaccine Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumococcal Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Pneumococcal Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of PPSV 23
Table 3. Major Manufacturers of PCV 7/13
Table 4. Major Manufacturers of PCV 10
Table 5. Global Pneumococcal Vaccine Market Size Growth Rate by End User (2021-2027) & (K Doses)
Table 6. Global Pneumococcal Vaccine Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Pneumococcal Vaccine Sales by Regions (2016-2021) & (K Doses)
Table 8. Global Pneumococcal Vaccine Sales Market Share by Regions (2016-2021)
Table 9. Global Pneumococcal Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Pneumococcal Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 11. Global Pneumococcal Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Pneumococcal Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Pneumococcal Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Pneumococcal Vaccine Sales by Manufacturers (2016-2021) (K Doses)
Table 15. Global Pneumococcal Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Pneumococcal Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Pneumococcal Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Pneumococcal Vaccine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccine as of 2020)
Table 21. Key Manufacturers Pneumococcal Vaccine Price (2016-2021) (USD/Dose)
Table 22. Pneumococcal Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pneumococcal Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Pneumococcal Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Pneumococcal Vaccine Sales by Type (2016-2021) (K Doses)
Table 27. Global Pneumococcal Vaccine Sales Share by Type (2016-2021)
Table 28. Global Pneumococcal Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Pneumococcal Vaccine Revenue Share by Type (2016-2021)
Table 30. Pneumococcal Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 31. Global Pneumococcal Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 32. Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Pneumococcal Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Pneumococcal Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Pneumococcal Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 36. Global Pneumococcal Vaccine Sales by End User (2016-2021) (K Doses)
Table 37. Global Pneumococcal Vaccine Sales Share by End User (2016-2021)
Table 38. Global Pneumococcal Vaccine Revenue by End User (2016-2021) (US$ Million)
Table 39. Global Pneumococcal Vaccine Revenue Share by End User (2016-2021)
Table 40. Pneumococcal Vaccine Average Selling Price (ASP) by End User (2016-2021) & (USD/Dose)
Table 41. Global Pneumococcal Vaccine Sales Forecast by End User (2022-2027) & (K Doses)
Table 42. Global Pneumococcal Vaccine Sales Market Share Forecast by End User (2022-2027)
Table 43. Global Pneumococcal Vaccine Revenue Forecast by End User (2022-2027) & (US$ Million)
Table 44. Global Pneumococcal Vaccine Revenue Market Share Forecast by End User (2022-2027)
Table 45. Global Pneumococcal Vaccine Average Selling Price (ASP) Forecast by End User (2022-2027) & (USD/Dose)
Table 46. China Pneumococcal Vaccine Sales (K Doses) of Key Companies (2016-2021)
Table 47. China Pneumococcal Vaccine Sales Share by Company (2016-2021)
Table 48. China Pneumococcal Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 49. China Pneumococcal Vaccine Revenue Share by Company (2016-2021)
Table 50. China Pneumococcal Vaccine Sales (K Doses) by Type (2016-2021)
Table 51. China Pneumococcal Vaccine Sales Share by Type (2016-2021)
Table 52. China Pneumococcal Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Pneumococcal Vaccine Price (USD/Dose) by Type (2016-2021)
Table 54. China Pneumococcal Vaccine Sales (K Doses) by Type (2022-2027)
Table 55. China Pneumococcal Vaccine Sales Share by Type (2022-2027)
Table 56. China Pneumococcal Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Pneumococcal Vaccine Revenue Share by Type (2022-2027)
Table 58. China Pneumococcal Vaccine Price (USD/Dose) by Type (2022-2027)
Table 59. China Pneumococcal Vaccine Sales (K Doses) by End User (2016-2021)
Table 60. China Pneumococcal Vaccine Sales Share by End User (2016-2021)
Table 61. China Pneumococcal Vaccine Revenue (US$ Million) Market Share by End User (2016-2021)
Table 62. China Pneumococcal Vaccine Price (USD/Dose) by End User (2016-2021)
Table 63. China Pneumococcal Vaccine Sales (K Doses) by End User (2022-2027)
Table 64. China Pneumococcal Vaccine Sales Share by End User (2022-2027)
Table 65. China Pneumococcal Vaccine Revenue (US$ Million) Market Share by End User (2022-2027)
Table 66. China Pneumococcal Vaccine Revenue Share by End User (2022-2027)
Table 67. China Pneumococcal Vaccine Price (USD/Dose) by End User (2022-2027)
Table 68. North America Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)
Table 69. North America Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 70. North America Pneumococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Pneumococcal Vaccine Sales by Region (2016-2021) & (K Doses)
Table 73. Asia Pacific Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Pneumococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)
Table 76. Europe Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)
Table 77. Europe Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 78. Europe Pneumococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)
Table 81. Latin America Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Pneumococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)
Table 85. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Pneumococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 88. Pfizer Corporation Information
Table 89. Pfizer Description and Business Overview
Table 90. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Pfizer Pneumococcal Vaccine Product
Table 92. Pfizer Recent Development
Table 93. GSK Corporation Information
Table 94. GSK Description and Business Overview
Table 95. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. GSK Product
Table 97. GSK Recent Development
Table 98. MSD Corporation Information
Table 99. MSD Description and Business Overview
Table 100. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. MSD Product
Table 102. MSD Recent Development
Table 103. Sanofipasteur Corporation Information
Table 104. Sanofipasteur Description and Business Overview
Table 105. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Sanofipasteur Product
Table 107. Sanofipasteur Recent Development
Table 108. CDIBP Corporation Information
Table 109. CDIBP Description and Business Overview
Table 110. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. CDIBP Product
Table 112. CDIBP Recent Development
Table 113. Pneumococcal Vaccine Market Trends
Table 114. Pneumococcal Vaccine Market Drivers
Table 115. Pneumococcal Vaccine Market Challenges
Table 116. Pneumococcal Vaccine Market Restraints
Table 117. Pneumococcal Vaccine Customers List
Table 118. Pneumococcal Vaccine Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. PPSV 23 Product Picture
Figure 4. PCV 7/13 Product Picture
Figure 5. PCV 10 Product Picture
Figure 6. Global Pneumococcal Vaccine Sales Market Share by End User in 2020 & 2027
Figure 7. Child
Figure 8. Adult
Figure 9. Pneumococcal Vaccine Report Years Considered
Figure 10. Global Pneumococcal Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pneumococcal Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global Pneumococcal Vaccine Sales 2016-2027 (K Doses)
Figure 13. Global Pneumococcal Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global Pneumococcal Vaccine Sales Market Share by Region in 2020
Figure 16. Global Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)
Figure 17. Global Pneumococcal Vaccine Revenue Market Share by Region in 2020
Figure 18. Global Pneumococcal Vaccine Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Pneumococcal Vaccine Revenue in 2020
Figure 20. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Figure 22. Global Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 23. Global Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)
Figure 24. Global Pneumococcal Vaccine Revenue Market Share by Type in 2020
Figure 25. Global Pneumococcal Vaccine Sales Market Share by End User (2016-2021)
Figure 26. Global Pneumococcal Vaccine Sales Market Share by End User in 2020
Figure 27. Global Pneumococcal Vaccine Revenue Market Share by End User (2016-2021)
Figure 28. Global Pneumococcal Vaccine Revenue Market Share by End User in 2020
Figure 29. China Pneumococcal Vaccine Sales Growth Rate 2016-2027 (K Doses)
Figure 30. China Pneumococcal Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Pneumococcal Vaccine Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Pneumococcal Vaccine Players Market Share by Revenue in Pneumococcal Vaccine in 2020
Figure 33. China Pneumococcal Vaccine Revenue Share by Type (2016-2021)
Figure 34. China Pneumococcal Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Pneumococcal Vaccine Revenue Share by End User (2016-2021)
Figure 36. China Pneumococcal Vaccine Revenue Growth Rate by End User in 2016 & 2020
Figure 37. North America Pneumococcal Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 38. North America Pneumococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 40. North America Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 41. U.S. Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 42. U.S. Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 44. Canada Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Pneumococcal Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 46. Europe Pneumococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 48. Europe Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 49. Germany Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 50. Germany Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 52. France Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 54. U.K. Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 56. Italy Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 58. Russia Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Pneumococcal Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 60. Asia Pacific Pneumococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Pneumococcal Vaccine Sales Market Share by Region in 2020
Figure 62. Asia Pacific Pneumococcal Vaccine Revenue Market Share by Region in 2020
Figure 63. China Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 64. China Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 66. Japan Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 68. South Korea Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 70. India Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 72. Australia Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 74. Taiwan Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 76. Indonesia Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 78. Thailand Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 80. Malaysia Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 82. Philippines Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 84. Vietnam Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Pneumococcal Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 86. Latin America Pneumococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 88. Latin America Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 89. Mexico Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 90. Mexico Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 92. Brazil Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 94. Argentina Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Pneumococcal Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 96. Middle East and Africa Pneumococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 99. Turkey Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 100. Turkey Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 102. Saudi Arabia Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. U.A.E Pneumococcal Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 104. U.A.E Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Pneumococcal Vaccine Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.